Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.
Explore this paper's citation graph
Summary
There is no firm evidence to support or refute TACE or TAE for patients with unresectable HCC, indicating the need for future randomisation of up to 383 additional participants.
- Type
- review
- Published
- 2011-03-16
- Cited by
- 276
- References
- 96
- Access
- Open access
- OpenAlex
- https://openalex.org/W1506777089
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:43420721
Keywords
Medicine, Meta-analysis, Hazard ratio, Clinical trial, Randomized controlled trial
References
- [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
- Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.
- Primary hepatic malignancy: surgical management and determinants of survival.
- [Percutaneous transfemoral arterial implantation of drug delivery system for arterial infusion therapy of advanced primary hepatic carcinoma].
- Postoperative Transhepatic Arterial Chemoembolization and Portal Vein Chemotherapy for Patients with Hepatocellular Carcinoma: A Randomized Study with 131 Cases
- Interaction revisited: the difference between two estimates
- Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial.
- LITERATURE SEARCHING FOR RANDOMIZED CONTROLLED TRIALS USED IN COCHRANE REVIEWS: RAPID VERSUS EXHAUSTIVE SEARCHES
- Systematic reviewers neglect bias that results from trials stopped early for benefit.
- Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.
- International trends and patterns of primary liver cancer
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
- Evaluating non-randomised intervention studies.
- Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: A prospective study
- Assessing the quality of reports of randomized clinical trials: is blinding necessary?
- Prospective randomized trial of chemoembolization versus intra‐arterial injection of 131I‐labeled–iodized oil in the treatment of hepatocellular carcinoma
- Efficacy of chemoembolization for hepatocellular carcinomas: Experience from the gustave roussy institute and the bicetre hospital
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.
- Results of combined treatment with transcatheter hepatic arterial chemoembolization and whole-liver irradiation with the moving strip technique in unresectable hepatocellular carcinoma
- New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Cited by
- Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines.
- CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma
- Radiological treatment of HCC: Interventional radiology at the heart of management.
- Management of hepatocellular carcinoma: Enlightening the gray zones.
- Lokalablative Therapien zur Behandlung des hepatozellulären Karzinoms
- Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma
- Palliation: treating patients with inoperable biliary tract and primary liver tumors.
- Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day.
- Chimioembolisation des carcinomes hépatocellulaires : une vieille méthode au goût du jour
- Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patients.
- Minimal invasive treatments for liver malignancies.
- Developments in cancer vaccines for hepatocellular carcinoma
- Hepatocellular carcinoma: Surgeon's view on latest findings and future perspectives.
- Saudi Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: Technical Review and Practice Guidelines
- Tyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adults
- Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma
- Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
- Cost‐effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria
- Transarterial (chemo)embolisation versus other nonsurgical ablation methods for liver metastases
- Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Related papers
- TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis
- Meta-Analysis on Randomized Controlled Trials of Tongxinluo Capsules for Cerebrovascular Disorders
- Mandibular advancement appliances for the treatment of obstructive sleep apnea in children: a systematic review and meta-analysis.
- Effectiveness and Safety of Amantadine in Parkinson Disease——a Meta-Analysis
- Effect of enhanced patient instructions on Helicobacter pylori eradication: A systematic review and meta‐analysis of randomized controlled trials
- Triclosan-Coated Sutures Reduce the Risk of Surgical Site Infections: A Systematic Review and Meta-analysis
- Effectiveness of Traditional Chinese Exercise for Symptoms of Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- The effectiveness of prenatal yoga on delivery outcomes: A meta-analysis.
- Effects of cranberry consumption on features of the metabolic syndrome: a systematic review and meta-analysis of randomized control trials
- Assisted hatching—a meta-analysis of randomized controlled trials